LR Roche

Recent news mentioning LR Roche

• 2026-09-22 — [Ad hoc announcement pursuant to Art. 53 LR] Roche announces positive Phase II results for dual GLP-1/GIP receptor agonist enicepatide in people living with type 2 diabetes and overweight or obesity

Appears alongside

• Phase II
• GLP-1/GIP

Browse the full archive →